Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • PATENT—D. Del.: Jury’s $107.5 million verdict against AstraZeneca vacated in lung cancer treatment litigation
    • BLOG TRACKER—Noteworthy blog posts and other commentary
    • COPYRIGHT—D. D.C.: Bad boys? Lawsuit against The Daily Caller over police videos can move forward
    • PATENT—D. Mass.: Court refuses to transfer suit against Mastercard to NY
    • PATENT—Fed. Cir.: Mixed results for Philips in wearable device infringement lawsuit against Garmin
    • TRADE SECRETS—D. Utah: Business analytics company failed to define claimed trade secrets
    • TRADEMARK—E.D. Pa.: Suit seeking cancellation of THE EDUCATION LAWYERS mark survives motion to dismiss
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    IP Law Daily, BLOG TRACKER—Noteworthy blog posts and other commentary, (Aug 15, 2024)

    Law Firms Mentioned:Akin Gump Strauss Hauer & Feld LLP | Goodwin Procter LLP | McDonnell Boehnen Hulbert & Berghoff LLP | Miller Nash LLP | Morrison Foerster LLP | Shearman & Sterling LLP | Wolf, Greenfield & Sacks, P.C.
    Organizations Mentioned:Akin Gump Strauss Hauer & Feld, LLP | Amgen | Goodwin Procter, LLP | McDonnell Boehnen Hulbert & Berghoff, LLP | Miller Nash, LLP | Morrison & Foerster, LLP | Shearman & Sterling, LLP | University of Missouri | Wolf, Greenfield & Sacks, PC

    By WK Editorial Staff

    The week’s most insightful, intriguing, or entertaining blog posts regarding intellectual property issues.

    • JD Supra, FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision, by Michael Siekman

    • Mondaq, ...

    By WK Editorial Staff

    The week’s most insightful, intriguing, or entertaining blog posts regarding intellectual property issues.

    • JD Supra, FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision, by Michael Siekman

    • Mondaq, Federal Circuit: First-Filed, First-Issued Patent Sets The Term For Obviousness-Type Double Patenting Analysis Even When Granted PTA, by Jason Weil and Rachel J. Elsby

    • Patently-O, No Sugar-Coating: Post-AIA Patent on Secret Process Barred by Pre-Filing Sale of Product, by Dennis Crouch (University of Missouri School of Law)

    • Hollywood Reporter, Artists Score Major Win in Copyright Case Against AI Art Generators, by Winston Cho

    • IP Watchdog, California Court Issues Mixed Order in Pivotal AI Copyright Case, by Lucas Thrun

    • IP Update, Digital Rights, Digital Wrongs: The DMCA Lives On, by Keval Amin

    • The Illusion of More, The EFF Campaign Against DMCA Section 1201 Perishes in the DC Circuit, by David Newhoff

    • MoFo Life Sciences Blog, The PTAB Axes Skin Treatment Patent under Amgen, by Yuxiang Chen and Mark D. McBriar Ph.D.

    • IP Litigation, Federal Circuit Provides Guidance On 35 U.S.C. § 102(b)(2)(B)’s Public Disclosure Exception To Prior Art, by Shearman & Sterling LLP

    • Patent Docs, 91%: That is the Rate at Which the PTAB Affirms Examiner Section 101 Rejections, by Michael Borella, Mackenna Dunn, and Garrett "Jake" Lee

    • TTABlog, Precedential No. 18: TTAB Grants Petition to Cancel BLOOKE Registration for Bicycles—Part I and Part II, by John Welch

    Attorneys: Michael Siekman (Goodwin Procter LLP). Jason Weil and Rachel J. Elsby (Akin Gump Strauss Hauer & Feld LLP). Keval Amin (Miller Nash LLP). Yuxiang Chen and Mark D. McBriar Ph.D. (Morrison Foerster LLP). (Shearman & Sterling LLP). Michael Borella, Mackenna Dunn, and Garrett Lee (McDonnell Boehnen Hulbert & Berghoff LLP). John L. Welch (Wolf, Greenfield & Sacks, P.C.).

    News: AINews Copyright Patent TechnologyInternet Trademark

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use